UNSPSC 51373421: Chlorpheniramine/hydrocodone/nh4/phenindamine/phenylephrine/pyrilamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373421 Chlorpheniramine/hydrocodone/nh4/phenindamine/phenylephrine/pyrilamine (Commodity) reflects state and local procurement of pharmaceutical products and medical supplies for correctional and public health applications. State and local governments buy parenteral nutrition solutions, intravenous fluids, controlled substances for incarcerated populations, naloxone, and drug deactivation systems under this code. The issuing bodies include state departments of corrections, county health departments, and community health authorities procuring supplies to meet statutory healthcare obligations and emergency-response needs.

The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, for parenteral products, services, and equipment to supply eight correctional facilities across the state, with a response date of October 7, 2026 and a pre-bid conference on September 23, 2026; DOC anticipates awarding up to three bidders per region and retains discretionary contract extensions beyond the initial term through June 30, 2030, with pricing firm for the first two years. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; that solicitation carried a July 26, 2023 response date, indicating either an archive error or extended availability. The code shows recent activity in the Pacific Northwest and Southeast, with contracting opportunities spanning state correctional systems and county community health operations.